J&J/Cordis Teramed Alliance Suggests Swifter Access To $1 Bil. AAA Market
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Cordis will join a crowded field of players in the worldwide abdominal aortic aneurysm (AAA) market, expected to top $1 bil. by 2008, following the acquisition of privately-held Teramed
You may also be interested in...
Cordis Stresses Durability Of Fortron AAA System, European Safety Results
The positive safety profile of Johnson & Johnson/ Cordis' Fortron abdominal aortic aneurysm (AAA) stent graft, as demonstrated in Europe, likely will be a key component of the firm's U.S. marketing strategy
Cordis Stresses Durability Of Fortron AAA System, European Safety Results
The positive safety profile of Johnson & Johnson/ Cordis' Fortron abdominal aortic aneurysm (AAA) stent graft, as demonstrated in Europe, likely will be a key component of the firm's U.S. marketing strategy
Cook Zenith AAA Endovascular Graft PMA Pending At FDA
Cook is expecting its Zenith abdominal aortic aneurysm endovascular stent-graft to go before FDA's Circulatory System Devices Panel this fall